Buy Rating Reaffirmed for Nurix Therapeutics: Promising Clinical Data and Increased Approval Probability for NX-5948
Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) and increased the price target ...
Nurix Therapeutics price target raised to $35 from $30 at H.C. Wainwright
H.C. Wainwright analyst Robert Burns raised the firm’s price target on Nurix Therapeutics (NRIX) to $35 from $30 and keeps a Buy rating on the ...
Is Nurix Therapeutics (NRIX) the Worst ARK Stock to Buy According to Short Sellers?
We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take ...